0:00
/
0:00
Transcript

Episode #3 - The Story Behind OvulaRing

Revolutionising Women's Health with Sebastian Alexander

In this episode of Femme Health Founders, we dive into the fascinating world of women's health innovation with Sebastian Alexander, founder and CEO of VivoSensMedical GmbH. We explore the journey of OvulaRing, a groundbreaking technology transforming the way we understand and address female fertility and gynaecological diagnostics.

From the legacy of Sebastian's father-in-law, a pioneer in IVF and reproductive medicine, to the challenges of building a company in an underfunded and often overlooked sector, this episode is a deep dive into the realities of advancing women's health.

Together, we discuss:

  • The unmet needs in women's reproductive health.

  • How core body temperature is revolutionising fertility diagnostics.

  • The gender data gap in healthcare and why it matters.

  • The importance of patient capital in driving women's health innovation.

  • How value-aligned investors can play a pivotal role in transforming the future of women's health.

If you’re an investor, founder, or simply someone passionate about advancing healthcare for women, this episode will inspire and inform you.

📢 Take Action: Watch the podcast now and share it with a friend who’s passionate about women’s health! Together, we can amplify the conversation.

#WomensHealth #FertilityInnovation #PatientCapital #FemTech


If you enjoyed this post, please share it widely! Also click the ❤️ or 🔄 button below so that more people can discover it 🙏

Share


Disclaimer

The content in this newsletter is for informational purposes only and does not constitute financial, investment, legal, or medical advice. Opinions expressed are those of the author and may not reflect the views of affiliated organisations. Readers should seek professional advice tailored to their individual circumstances before making decisions. Investing involves risk, including potential loss of principal. Past performance does not guarantee future results.

Leave a comment